Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variants
C.-P. Chen, K.-Y. A. Huang, S.-R. Shih…·S.-H. Cheng
This study examines spike-specific antibody responses in SARS-CoV-2 natural infections, showing waning immunity over 11 months and reduced activity against emerging variants like Beta and Omicron.